These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29723379)

  • 1. Oxidative stress in patients with endemic pemphigus foliaceus and healthy subjects with anti-desmoglein 1 antibodies.
    Gutierrez EL; Ramos W; Seminario-Vidal L; Tello M; Ronceros G; Ortega-Loayza AG
    An Bras Dermatol; 2018 Mar; 93(2):212-215. PubMed ID: 29723379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against desmoglein 1 in healthy subjects in endemic and nonendemic areas of pemphigus foliaceus (fogo selvagem) in Peru.
    Ortega Loayza AG; Ramos W; Elgart G; Bouman P; Jiménez G; Avila J; Rojas I; Vilcarromero M; Hurtado J; Lindo G; Galarza C
    Int J Dermatol; 2006 May; 45(5):538-42. PubMed ID: 16700787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
    Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
    Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidesmoglein 1 and 3 antibodies in healthy subjects of a population in the Peruvian high amazon.
    Ramos W; Díaz J; Gutierrez EL; Lazarte JS; Bohnett MC; Ronceros G; Ortega-Loayza AG
    Int J Dermatol; 2018 Mar; 57(3):344-348. PubMed ID: 29130480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endemic pemphigus foliaceus in the Peruvian Amazon.
    Ortega-Loayza AG; Ramos W; Gutierrez EL; Jimenez G; Rojas I; Galarza C
    Clin Exp Dermatol; 2013 Aug; 38(6):594-600. PubMed ID: 23692307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from Tunisia.
    Abida O; Kallel-Sellami M; Joly P; Ben Ayed M; Zitouni M; Masmoudi A; Mokni M; Fezzaa B; Ben Osman A; Kammoun MR; Gilbert D; Turki H; Tron F; Masmoudi H; Makni S;
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1073-8. PubMed ID: 19453789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research.
    Warren SJ; Lin MS; Giudice GJ; Hoffmann RG; Hans-Filho G; Aoki V; Rivitti EA; Santos V; Diaz LA
    N Engl J Med; 2000 Jul; 343(1):23-30. PubMed ID: 10882765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
    Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P
    Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.
    Kallel Sellami M; Ben Ayed M; Mouquet H; Drouot L; Zitouni M; Mokni M; Cerruti M; Turki H; Fezza B; Mokhtar I; Ben Osman A; Zahaf A; Kamoun MR; Joly P; Masmoudi H; Makni S; Tron F; Gilbert D
    Clin Exp Immunol; 2004 Jul; 137(1):195-200. PubMed ID: 15196262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus.
    Kumar B; Arora S; Kumaran MS; Jain R; Dogra S
    Indian J Dermatol Venereol Leprol; 2006; 72(3):203-6. PubMed ID: 16766834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune reactivity against precursor form of desmoglein 1 in healthy Tunisians in the area of endemic pemphigus foliaceus.
    Toumi A; Saleh MA; Yamagami J; Abida O; Kallel M; Masmoudi A; Makni S; Turki H; Hachiya T; Kuroda K; Stanley JR; Masmoudi H; Amagai M
    J Dermatol Sci; 2013 Apr; 70(1):19-25. PubMed ID: 23489520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus.
    Diaz LA; Prisayanh PS; Dasher DA; Li N; Evangelista F; Aoki V; Hans-Filho G; dos Santos V; Qaqish BF; Rivitti EA;
    J Invest Dermatol; 2008 Mar; 128(3):667-75. PubMed ID: 17960181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
    J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural skin alterations of healthy subjects with
    Ramos W; Rojas N; Ortega-Loayza AG; Tello M; Jiménez G; Cuba-Cáceres N; Ronceros G; De La Cruz-Vargas JA; Vera-Ponce VJ; Guerrero N; Gutierrez EL
    J Transl Autoimmun; 2023 Dec; 7():100208. PubMed ID: 37520889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
    Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
    Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
    Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
    Barnadas MA; Rubiales MV; Gich I; Gelpí C
    Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalase and lipid peroxidation values in serum of Tunisian patients with pemphigus vulgaris and foliaceus.
    Abida O; Ben Mansour R; Gargouri B; Ben Ayed M; Masmoudi A; Turki H; Masmoudi H; Lassoued S
    Biol Trace Elem Res; 2012 Dec; 150(1-3):74-80. PubMed ID: 22907559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
    Kamiya K; Aoyama Y; Yamasaki O; Kamata A; Yamagami J; Iwatsuki K; Tokura Y
    Br J Dermatol; 2016 Jan; 174(1):113-9. PubMed ID: 26294113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.